Anika Therapeutics buy B. Riley
Start price
17.04.25
/
50%
€12.30
Target price
17.04.26
€18.48
Performance (%)
-34.96%
Price
17.12.25
€8.05
Summary
This prediction is currently active. The BUY prediction by B__Riley for Anika Therapeutics is performing very badly with a performance of -34.96%. This prediction currently runs until 17.04.26. The prediction end date can be changed by B__Riley at any time. B__Riley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Anika Therapeutics | -1.227% | -1.227% |
| iShares Core DAX® | -0.793% | 4.201% |
| iShares Nasdaq 100 | -2.376% | 0.857% |
| iShares Nikkei 225® | -2.701% | -0.147% |
| iShares S&P 500 | -1.689% | 1.244% |
Comments by B__Riley for this prediction
In the thread Anika Therapeutics diskutieren
Anika Therapeutics, Inc. (NASDAQ: ANIK) is now covered by analysts at B. Riley. They set a "buy" rating and a $21.00 price target on the stock.
Ratings data for ANIK provided by MarketBeat